Related Experiment Video
Updated: Aug 12, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
World conference on lung cancer
Enriqueta Felip1, Rafael Rosell
1Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.
Expert Opinion on Biological Therapy
|December 4, 2003
Summary
The 10th World Conference on Lung Cancer convened over 3000 experts to discuss advancements in lung cancer treatment and research. This international collaboration aimed to improve outcomes for the leading cause of cancer mortality worldwide.
Area of Science:
- Oncology
- Pulmonology
- Medical Conferences
Background:
- Lung cancer remains the leading cause of cancer-related mortality globally.
- Effective management necessitates multidisciplinary collaboration among specialists.
- The 10th World Conference on Lung Cancer addressed critical issues in the field.
Framework:
- Organized by the International Association for the Study of Lung Cancer (IASLC) and the British Columbia Cancer Agency.
- Chaired by Nevin Murray, the conference took place in Vancouver, Canada.
- Featured a comprehensive program from August 10-14.
Implementation:
- Over 3000 lung cancer experts participated in the event.
- Included over 140 invited speakers in various session formats.
- Showcased 300 oral and 500 poster presentations of cutting-edge research.
Implications:
- Fostered international collaboration to improve lung cancer patient outcomes.
- Disseminated the latest research findings and treatment strategies.
- Advanced the global understanding and management of lung cancer.
Related Concept Videos
01:47Lung Capacity
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...